HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Earth Solutions

This article was originally published in The Rose Sheet

Executive Summary

DermAlive, "an aromatherapy nutrient healing gel for healthy and problem skin types," is Atlanta, Ga.-based aromatherapy company's entry into the skin care market. Launching now, the formula contains dissolved oxygen, colloidal materials, plant enzymes, amino acids, aloe vera, lavender and comfrey. The ingredients calm skin and seal in nutrients, Earth Solutions said. Additional essential oils of lavender also provide an aromatherapeutic effect: the product works to "soothe your skin while calming your spirit," the company added. The clear gel formula is packaged in a jar decorated with Earth Solution's signature brightly colored folk art. Retail price is $15 for 2 oz

DermAlive, "an aromatherapy nutrient healing gel for healthy and problem skin types," is Atlanta, Ga.-based aromatherapy company's entry into the skin care market. Launching now, the formula contains dissolved oxygen, colloidal materials, plant enzymes, amino acids, aloe vera, lavender and comfrey. The ingredients calm skin and seal in nutrients, Earth Solutions said. Additional essential oils of lavender also provide an aromatherapeutic effect: the product works to "soothe your skin while calming your spirit," the company added. The clear gel formula is packaged in a jar decorated with Earth Solution's signature brightly colored folk art. Retail price is $15 for 2 oz.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005887

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel